Alcohol dependence is a chronic disorder that results from avariety of genetic, psychosocial, and environmental factors.1As defined by the American Psychiatric Association in the Diagnosticand Statistical Manual of Mental Disorders, it is characterizedby increased tolerance of the effects of alcohol, impaired controlover drinking, and continued drinking despite adverse consequences(Table 1).2 Alcohol dependence affects nearly 10 percent ofthe population and results in social problems, considerablemorbidity and mortality, and high health care costs.3,4
View this table: [in this window]
[in a new window]
Table 1. Criteria for Alcohol Dependence.
Alcohol dependence is treated by medical, psychological, andsocial interventions that reduce or eliminate the . . . [Full Text of this Article]
The Neurobehavioral Aspects of Alcohol Dependence
Drug Treatment for Alcohol Dependence
Aversive Drugs
Opioid Antagonists
Acamprosate
Dopaminergic Drugs
Other Drugs
Mood Stabilizers
Sedative Drugs
Serotonergic Drugs
Patients with Psychiatric Disorders
Recommendations
Conclusions
Source Information
From the Center for Alcohol and Addiction Studies and the Department of Psychiatry, Brown University Medical School and the Veterans Affairs Medical Center, Providence, R.I.
Address reprint requests to Dr. Swift at ACOS for Research and Education, Veterans Affairs Medical Center, 830 Chalkstone Ave., Providence, RI 02908, or at robert_swift@brown.edu.
References
This article has been cited by other articles:
Kuhn, J., Lenartz, D., Huff, W., Lee, S.-H., Koulousakis, A., Klosterkoetter, J., Sturm, V.
(2009). Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?. BMJ Case Reports
2009: bcr0720080539-bcr0720080539
[Abstract][Full Text]
Olmsted, C. L, Kockler, D. R
(2008). Topiramate for Alcohol Dependence. The Annals of Pharmacotherapy
42: 1475-1480
[Abstract][Full Text]
Leggio, L., Addolorato, G.
(2008). Invited Commentary * Serotonin transporter (SERT) brain density and neurobiological cloninger subtypes model: a lesson by human autoradiography studies. Alcohol Alcohol
43: 148-150
[Abstract][Full Text]
Kuhn, J., Lenartz, D., Huff, W., Lee, S., Koulousakis, A., Klosterkoetter, J., Sturm, V.
(2007). Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?. J. Neurol. Neurosurg. Psychiatry
78: 1152-1153
[Abstract][Full Text]
SWIFT, R.
(2007). Emerging approaches to managing alcohol dependence. Am J Health Syst Pharm
64: S12-S22
[Abstract][Full Text]
Mason, B. J.
(2006). Acamprosate for Alcohol Dependence: An Update for the Clinician. Focus
4: 505-
[Abstract][Full Text]
Watkins, K. E., Hunter, S. B., Burnam, M. A., Pincus, H. A., Nicholson, G.
(2005). Review of Treatment Recommendations for Persons With a Co-occurring Affective or Anxiety and Substance Use Disorder. Psychiatr. Serv.
56: 913-926
[Abstract][Full Text]
Lingford-Hughes, A. R., Welch, S., Nutt, D. J.
(2004). Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol
18: 293-335
Cami, J., Farre, M.
(2003). Drug Addiction. NEJM
349: 975-986
[Full Text]
Weiss, R. D., Griffin, M. L., Mazurick, C., Berkman, B., Gastfriend, D. R., Frank, A., Barber, J. P., Blaine, J., Salloum, I., Moras, K.
(2003). The Relationship Between Cocaine Craving, Psychosocial Treatment, and Subsequent Cocaine Use. Am. J. Psychiatry
160: 1320-1325
[Abstract][Full Text]
Sloan, T. B., Roache, J. D., Johnson, B. A.
(2003). THE ROLE OF ANXIETY IN PREDICTING DRINKING BEHAVIOUR. Alcohol Alcohol
38: 360-363
[Abstract][Full Text]
Overman, G. P, Teter, C. J, Guthrie, S. K
(2003). Acamprosate for the Adjunctive Treatment of Alcohol Dependence. The Annals of Pharmacotherapy
37: 1090-1099
[Abstract][Full Text]
Addolorato, G., Caputo, F., Capristo, E., Domenicali, M., Bernardi, M., Janiri, L., Agabio, R., Colombo, G., Gessa, G. L., Gasbarrini, G.
(2002). BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY. Alcohol Alcohol
37: 504-508
[Abstract][Full Text]
de Wildt, W. A. J. M., Schippers, G. M., van den Brink, W., Potgieter, A. S., Deckers, F., Bets, D.
(2002). DOES PSYCHOSOCIAL TREATMENT ENHANCE THE EFFICACY OF ACAMPROSATE IN PATIENTS WITH ALCOHOL PROBLEMS?. Alcohol Alcohol
37: 375-382
[Abstract][Full Text]
Streeton, C., Whelan, G.
(2001). NALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Alcohol Alcohol
36: 544-552
[Abstract][Full Text]
Filley, C. M., Kleinschmidt-DeMasters, B.K.
(2001). Toxic Leukoencephalopathy. NEJM
345: 425-432
[Full Text]
Wiesbeck, G. A., Weijers, H.-G., Lesch, O. M., Glaser, T., Toennes, P.-J., Boening, J.
(2001). Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alcohol Alcohol
36: 329-334
[Abstract][Full Text]
Tomkins, D. M., Sellers, E. M.
(2001). Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. CMAJ
164: 817-821
[Abstract][Full Text]
Gerlach, M., Blum-Degen, D., Ransmayr, G., Leblhuber, F., Pedersen, V., Riederer, P.
(2001). Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain. Alcohol Alcohol
36: 65-69
[Abstract][Full Text]
Garver, E., Ross, A. D., Tu, G.-C., Cao, Q.-N., Zhou, F., Israel, Y.
(2000). PARADIGM TO TEST A DRUG-INDUCED AVERSION TO ETHANOL. Alcohol Alcohol
35: 435-438
[Abstract][Full Text]